Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC) ; day:16 ; month:10 ; year:2024
South Asian journal of cancer ; (16.10.2024)
- Beteiligte Personen und Organisationen
-
Parikh, Purvish M.
Biswas, Ghanashyam
Dhamne, Nilesh Ashok
Deshmukh, Chetan Dilip
Limaye, Sewanti
Singh, Ashish
Malhotra, Hemant
Maniar, Viashsta Pankaj
Kapur, Bhupendra Nath
Sripada, Prasad V.S.S.
Talreja, Vikas Tulsidas
Patil, Poonam
Agre, Suhas Vilasrao
Bhat, Amit Dilip
Nayak, Priya Privadarshini
Seshachalam, Arun
Dhabhar, Boman Nariman
Sharma, Ajay
Bhatt, Niraj N.
Das, Pratap Kishore
Sharma, Atul
Kanakasetty, Govind Babu
Advani, Suresh Hariram
- DOI
-
10.1055/s-0044-1791783
- URN
-
urn:nbn:de:101:1-2412261034106.438619744673
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Parikh, Purvish M.
- Biswas, Ghanashyam
- Dhamne, Nilesh Ashok
- Deshmukh, Chetan Dilip
- Limaye, Sewanti
- Singh, Ashish
- Malhotra, Hemant
- Maniar, Viashsta Pankaj
- Kapur, Bhupendra Nath
- Sripada, Prasad V.S.S.
- Talreja, Vikas Tulsidas
- Patil, Poonam
- Agre, Suhas Vilasrao
- Bhat, Amit Dilip
- Nayak, Priya Privadarshini
- Seshachalam, Arun
- Dhabhar, Boman Nariman
- Sharma, Ajay
- Bhatt, Niraj N.
- Das, Pratap Kishore
- Sharma, Atul
- Kanakasetty, Govind Babu
- Advani, Suresh Hariram
Ähnliche Objekte (12)
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Einfluss des AurkA Phe31Ile-Polymorphismus auf das Ansprechen von Cetuximab bei HNSCC Patienten
Cilengitide und Cetuximab in Plattenepithelkarzinomen der Kopf-Hals-Region (HNSCC): Zytokinproduktion von HNSCC im Ex-vivo-Chemoresponsetest FLAVINO als Indikator heterogenen Therapieansprechens
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma : SATB1 in HNSCC
Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Einfluss des AurkA Phe31Ile-Polymorphismus auf das Ansprechen von Cetuximab bei HNSCC Patienten
Cilengitide und Cetuximab in Plattenepithelkarzinomen der Kopf-Hals-Region (HNSCC): Zytokinproduktion von HNSCC im Ex-vivo-Chemoresponsetest FLAVINO als Indikator heterogenen Therapieansprechens
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma : SATB1 in HNSCC
Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Einfluss des AurkA Phe31Ile-Polymorphismus auf das Ansprechen von Cetuximab bei HNSCC Patienten
Cilengitide und Cetuximab in Plattenepithelkarzinomen der Kopf-Hals-Region (HNSCC): Zytokinproduktion von HNSCC im Ex-vivo-Chemoresponsetest FLAVINO als Indikator heterogenen Therapieansprechens
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma : SATB1 in HNSCC
Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines